• ALung Technologies, now a part of LivaNova
About • ALung Technologies, now a part of LivaNova
ALung Technologies, Inc. is proud to be a part of LivaNova. ALung developed the Hemolung for treating patients with acute respiratory failure. The Hemolung provides a simple, less invasive form of extracorporeal CO2 removal. By removing carbon dioxide and delivering oxygen directly to the blood, the Hemolung allows the patient’s lungs to rest and heal.
Find • ALung Technologies, now a part of LivaNova Execs' Valid Emails
Up to 90% verified emails and mobile numbers, refreshed weekly.
Company Details
1B-10B
Medical Devices
1,001-5,000 employees
Public Company
Pittsburgh, PA
United States
Frequently Asked Questions about
What is • ALung Technologies, now a part of LivaNova's industry?
• ALung Technologies, now a part of LivaNova operates in the Medical Devices industry and is headquartered in United States.
How many employees does • ALung Technologies, now a part of LivaNova have?
• ALung Technologies, now a part of LivaNova has approximately 1,001-5,000 employees employees.
Where is • ALung Technologies, now a part of LivaNova's based?
• ALung Technologies, now a part of LivaNova is based in Pittsburgh, PA, United States.
Is • ALung Technologies, now a part of LivaNova publicly listed?
Yes. • ALung Technologies, now a part of LivaNova is a publicly traded company.
How can I contact • ALung Technologies, now a part of LivaNova's investor relations team?
You can reach • ALung Technologies, now a part of LivaNova’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Find verified emails and phone numbers for professionals like those at
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
Find verified emails at this company
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.